close

Enter

Log in using OpenID

Cardiac Rhythm Management Devices Market

embed
Cardiac Rhythm Management (CRM) devices include pacemakers (PMs), implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices.
Cardiac Rhythm Management Devices Market Size, Share, Outlook, and Opportunity Analysis,
2018-2026
Cardiac Rhythm Management (CRM) devices include pacemakers (PMs), implantable
cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices. These
devices perform various functions, including bradycardia pacing, cardiac resynchronization for
heart failure, monitoring for arrhythmias, defibrillation, and anti-tachycardia pacing for
tachyarrhythmia. Products such as cardiac resynchronization therapy can improve congestive
heart failure symptoms by improving the timing of the heart’s contractions, resulting in
pumping more blood to the body.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/2364
The global cardiac rhythm management devices market size was valued at US$ 19.05 billion in
2017, and is expected to witness a CAGR of 7.5% over the forecast period (2018 – 2026).
Market Dynamics
Increasing incidences of heart failure and arrhythmia have fuelled rapid advancements in
cardiac rhythm management (CRM) technologies eventually increasing the demand for CRM
devices. According to the study published in 2016, by the Journal of the Formosan Medical
Association, around 72 million people are estimated to suffer from atrial fibrillation in Asia by
2050, which is expected to be more than double the combined numbers of patients from the
U.S. and Europe.
However, factors such as chances of infections associated with installation of pacemakers in
cardiac patients can hamper the cardiac rhythm management devices market growth. Pacemaker
surgery can also led to various complications such as bleeding, bruising or swelling at the of
area of pacemaker implantation leading to blood vessel or nerve damage, which in turn can
reduce adoption of cardiac implants in patients.
Report includes chapters which deeply display the following deliverable about industry :
• Cardiac Rhythm Management Devices Market Research Objective and Assumption
• Cardiac Rhythm Management Devices Market Purview - Report Description, Executive
Summary, and Coherent Opportunity Map (COM)
• Cardiac Rhythm Management Devices Market Dynamics, Regulations, and Trends Analysis Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Cardiac Rhythm Management Devices Market, By Regions
• Cardiac Rhythm Management Devices Market Competition by Manufacturers including
Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and
Product Type.
• Cardiac Rhythm Management Devices Market Manufacturers Profiles/Analysis including
Company Basic Information, Manufacturing Base and Its Competitors.
• Cardiac Rhythm Management Devices Market Manufacturing Cost Analysis including Key Raw
Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Cardiac Rhythm Management Devices Market Forecast including Production, Consumption,
Import and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Rising incidences of cardiac disorders worldwide is expected to drive the cardiac rhythm
management devices market revenue
Rise in incidence of cardiovascular diseases such as cardiac arrhythmia, ischemic heart disease,
and hypertension is expected to fuel growth of the cardiac rhythm management devices market.
According to WHO report, in 2015, cardiovascular diseases was the leading cause of deaths
accounting for 17.7 million deaths, worldwide.
Furthermore, technological advancements in cardiac rhythm management devices is the major
growth rendering factor for the industry. For instance, adoption of advanced technologies in
cardiac pacemakers such as pacemakers with improved battery life and MRI safe-pacemakers,
delay the progression of persistent atrial fibrillation (AF) in patients suffering from bradycardia.
These advancements are gaining significant traction and are expected to fuel the demand for
cardiac rhythm management devices. For instance, in February 2017, Abbott received the Food
and Drug Administration (FDA) approval for its MR-conditional labeling for Assurity MRI
pacemaker and the Tendril MRI pacing lead.
Inquire Here Before Purchase of Research Report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/2364
Cardiac Rhythm Management Devices Market - Competitive Landscape
Key players operating in the global cardiac rhythm management devices market include
Medtronic plc. Abbott Laboratories, Abiomed, Boston Scientific Corporation, Biotronik Se Co Kg,
Koninklijke Philips N.V., LivaNova Plc, Cardiac Science Corporation, Schiller Ag, and Zoll
Medical Corporation.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Author
Alex Huge
Alex Huge201   document Email
Document
Category
Health and Medicine
Views
10
File Size
109 KB
Tags
management, Cardiac Rhythm Management Devices Market
1/--pages
Report inappropriate content